Literature DB >> 22851040

Balance of CD8+ CD28+ / CD8+ CD28- T lymphocytes is vital for patients with ulcerative colitis.

Shi-Xue Dai1, Gang Wu, Ying Zou, Yan-Ling Feng, Hong-Bo Liu, Jin-Shan Feng, Hong-Gang Chi, Ru-Xi Lv, Xue-Bao Zheng.   

Abstract

BACKGROUND: Immune balances are important for many diseases including ulcerative colitis (UC). This study aimed to explore the role of the balance between CD8+ CD28+ and CD8+ CD28- T lymphocytes for the immunological pathogenesis of UC.
METHODS: Sixteen patients with UC, 16 patients with irritable bowel syndrome (IBS) and 15 healthy volunteers were enrolled. The frequencies of CD8+ CD28+ and CD8+CD28- T lymphocytes in peripheral blood and colon tissue were tested using flow cytometry and immunofluorescent, respectively. The cytokines of the two lymphocytes were detected by protein chips and ELISA. The expression of the signal transducers, the JAK3 and STAT6, as well the transcription factors, the NFATc2 and GATA3, was all detected by both western blot and immunohistochemistry.
RESULTS: For UC patients, the frequencies of CD8+ CD28+ T lymphocytes, together with the ratios of CD8+ CD28+ / CD8+ CD28- T lymphocytes in blood and colon tissue, were significantly lower than those in both IBS patients and healthy volunteers. But the frequencies of CD8+ CD28- T lymphocytes in blood and colon tissue of the UC patients were significantly higher than the other two groups. The concentration of IL-7 and -13, and the expression of JAK3 and STAT6 in UC patients, were significantly lower when compared with the other two groups. Conversely, the concentration of IL-12p40 and -15, and the expression of GATA3 and NFATc2 in UC patients, were significantly higher than both IBS and control group.
CONCLUSIONS: The balance of CD8+ CD28+ / CD8+ CD28- T lymphocytes plays a vital role in UC, while the balance tilt towards CD8+ CD28+ T lymphocytes is beneficial for patients with UC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22851040     DOI: 10.1007/s10620-012-2327-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Defect in CEACAM family member expression in Crohn's disease IECs is regulated by the transcription factor SOX9.

Authors:  Giulia Roda; Stephanie Dahan; Laura Mezzanotte; Alessandra Caponi; Franziska Roth-Walter; David Pinn; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2009-07-27       Impact factor: 5.325

2.  GATA3 siRNA inhibits the binding of NFAT1 to interleukin-13 promoter in human T cells.

Authors:  Xin Yao; Yan Yang; Hai-yan He; Min Wang; Kai-sheng Yin; Mao Huang
Journal:  Chin Med J (Engl)       Date:  2010-03-20       Impact factor: 2.628

3.  Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn's disease.

Authors:  D T Førland; E Johnson; L Saetre; T Lyberg; I Lygren; G Hetland
Journal:  Scand J Immunol       Date:  2011-01       Impact factor: 3.487

4.  Heterogeneity in phenotype and function of CD8+ and CD4/CD8 double-negative Natural Killer T cell subsets in sooty mangabeys.

Authors:  Namita Rout; James G Else; Simon Yue; Michelle Connole; Mark A Exley; Amitinder Kaur
Journal:  J Med Primatol       Date:  2010-08       Impact factor: 0.667

5.  Gene expression in IFNß signalling pathway differs between monocytes, CD4 and CD8 T cells from MS patients.

Authors:  B Oliver-Martos; T Órpez; M J Pinto-Medel; C Mayorga; J A García-León; R Maldonado-Sanchez; M Suardíaz; M Guerrero; G Luque; L Leyva; O Fernández
Journal:  J Neuroimmunol       Date:  2010-11-24       Impact factor: 3.478

6.  CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice.

Authors:  Ingrid Ménager-Marcq; Céline Pomié; Paola Romagnoli; Joost P M van Meerwijk
Journal:  Gastroenterology       Date:  2006-09-08       Impact factor: 22.682

7.  Delayed resolution of acute inflammation in ulcerative colitis is associated with elevated cytokine release downstream of TLR4.

Authors:  Farooq Z Rahman; Andrew M Smith; Bu'Hussain Hayee; Daniel J B Marks; Stuart L Bloom; Anthony W Segal
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

8.  Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes.

Authors:  Taku Kobayashi; Susumu Okamoto; Yuko Iwakami; Atsushi Nakazawa; Tadakazu Hisamatsu; Hiroshi Chinen; Nobuhiko Kamada; Toshio Imai; Hidemi Goto; Toshifumi Hibi
Journal:  Inflamm Bowel Dis       Date:  2007-07       Impact factor: 5.325

9.  T-cell activation in patients with irritable bowel syndrome.

Authors:  Lena Ohman; Stefan Isaksson; Ann-Charlotte Lindmark; Iris Posserud; P-O Stotzer; Hans Strid; Henrik Sjövall; Magnus Simrén
Journal:  Am J Gastroenterol       Date:  2009-04-14       Impact factor: 10.864

10.  Impaired IL-4 phosphorylation of STAT6 in EBV transformed B-cells.

Authors:  Lisa S Poritz; Wen Jie Zhang; Jennifer Thompson; Morgan Boyer; Clarence Clark; Walter A Koltun
Journal:  J Surg Res       Date:  2009-01-27       Impact factor: 2.192

View more
  7 in total

Review 1.  Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives.

Authors:  Matthew S Farina; Kevin T Lundgren; Joaquim Bellmunt
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

2.  Disequilibrium in the CD8+CD28+/CD8+CD28- T Lymphocyte Balance Is Related to Prognosis in Rats with Trinitrobenzenesulfonic Acid-Induced Colitis.

Authors:  Shixue Dai; Hongxiang Gu; Qianyi Lin; Tiaosi Xing; Minhua Chen; Tao Zhong; Gang Wu; Yanling Feng; Hongbo Liu; Yong Gao; Hongjian Jian; Minhai Zhang; Hongmei Mo; Huanjie Zhu; Dongsheng Chen; Jun Xu; Ying Zou; Honggang Chi; Yuzhen Zhu
Journal:  Dig Dis Sci       Date:  2016-12-29       Impact factor: 3.199

3.  Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis.

Authors:  Ji Yong Ahn; Kyung Hun Lee; Chang Hwan Choi; Ju Wan Kim; Hyun Woong Lee; Jeong Wook Kim; Mi Kyung Kim; Gui Young Kwon; Seungbong Han; Seong-Eun Kim; Sung Min Kim; Sae Kyung Chang
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

4.  Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis.

Authors:  Jayshree Mishra; Raj K Verma; Gianfranco Alpini; Fanyin Meng; Narendra Kumar
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

5.  Decreased CD8+CD28+/CD8+CD28- T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease.

Authors:  Shi-Xue Dai; Hong-Xiang Gu; Qian-Yi Lin; Yan-Kun Wu; Xiao-Yan Wang; Shao-Zhuo Huang; Tiao-Si Xing; Min-Hua Chen; Qing-Fang Zhang; Zhong-Wen Zheng; Wei-Hong Sha
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 6.  Harnessing CD8+CD28- Regulatory T Cells as a Tool to Treat Autoimmune Disease.

Authors:  Sabrina Ceeraz; Charlotte R Thompson; Richard Beatson; Ernest H Choy
Journal:  Cells       Date:  2021-11-01       Impact factor: 6.600

7.  Changes of costimulatory molecule CD28 on circulating CD8+ T cells correlate with disease pathogenesis of chronic hepatitis B.

Authors:  Xuefen Li; Haishen Kong; Li Tian; Qiaoyun Zhu; Yiyin Wang; Yuejiao Dong; Qin Ni; Yu Chen
Journal:  Biomed Res Int       Date:  2014-06-10       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.